13F filing recap · Q2 2024
What did ArrowMark Partners buy in Q2 2024?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every ArrowMark account, including accounts that belong to no fund below.
Stock value
$8.39B
Positions
312
Estimated turnover
19.0%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
CHWYChewy, Inc.$71.56Mreported value+2.63M sharesWAYWaystar Holding Corp.$53.59Mreported value+2.49M sharesCNMDConmed Corporation$34.51Mreported value+497.8K sharesULSUl Solutions Inc.$14.55Mreported value+344.9K sharesFIVEFive Below, Inc.$11.99Mreported value+110.0K sharesLUVSouthwest Airlines Co.$11.64Mreported value+406.7K sharesKNSAKiniksa Pharmaceuticals International, PlcMIXED CORP ACTION$11.37Mreported value+608.9K sharesEVRGEvergy, Inc.$11.12Mreported value+210.0K sharesLVSLas Vegas Sands Corp$9.61Mreported value+217.2K sharesIBTAIbotta, Inc.$7.94Mreported value+105.6K sharesGENIGenius Sports Limited$5.55Mreported value+1.02M sharesTEMTempus Ai, Inc.$4.38Mreported value+125.0K sharesIARTIntegra Lifesciences Holdings Corp$4.31Mreported value+148.0K sharesTITNTitan Machinery Inc.$4.23Mreported value+266.1K sharesRDUSRadius Recycling Inc$3.02Mreported value+198.0K sharesINBXInhibrx Biosciences, Inc.$2.16Mreported value+152.2K sharesINSMInsmed Incorporated$2.01Mreported value+30.0K shares